RE:Breaking NewsI guess Pfizer has a little weight at the White House and to bring forth a new class of cannabinoid based drugs. Biden selected 10 drugs yesterday to renegotiate pricing to reduce government spending costs on Medicare. Pfizer also some has some revenue coming their way with the build up of the 'trippledemic'....COVID, Influenza, RSV. Plenty of pocket change to finally make their move with LABS.
Considering the NIH (U.S. Federal) is funding cannbinoid based clinical trials and the DEA allowed the importation of THC containing API's from LABS, the news of descheduling was only a matter of time.
Like Bourla said, 1 in 3 will be affected by cancer in their life times. Pfizer, City of Hope Duarte California and cannabinoid based API's.
Peace and tranquility.